Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 537034-17-6 Chemical Structure| 537034-17-6

Structure of BML-210
CAS No.: 537034-17-6

Chemical Structure| 537034-17-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BML-210 is the HDAC inhibitor, and its mechanism of action has not been characterized.

Synonyms: N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide; CAY10433

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BML-210

CAS No. :537034-17-6
Formula : C20H25N3O2
M.W : 339.43
SMILES Code : O=C(NC1=CC=CC=C1N)CCCCCCC(NC2=CC=CC=C2)=O
Synonyms :
N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide; CAY10433
English Name :N1-(2-Aminophenyl)-N8-phenyloctanediamide
MDL No. :MFCD08062139
InChI Key :RFLHBLWLFUFFDZ-UHFFFAOYSA-N
Pubchem ID :9543540

Safety of BML-210

Related Pathways of BML-210

epigenetics

Isoform Comparison

Biological Activity

Description
BML-210 acts as a strong inhibitor of HDAC, able to suppress the HDAC4-VP16-driven reporter activity with an IC50 of approximately 5 µM. It specifically disrupts the HDAC4:MEF2 interaction, leads to an accumulation of cells in the G0/G1 phase, and promotes apoptosis, demonstrating antitumor efficacy in orthotopic mammary tumors in mice[1].[2].[3].

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 10 µM overnight To detect the interaction between HDAC4 and MEF2D Nucleic Acids Res. 2012 Jul;40(12):5378-88
NIH 3T3 cells 10 µM overnight To examine the effect of BML-210 analogs on HDAC4:MEF2 interaction Nucleic Acids Res. 2012 Jul;40(12):5378-88
MDA-MB-468 cells 1μM 48 h Promote antigen presentation and enhance CD8+ T cell-mediated cytotoxicity Nat Biomed Eng. 2021 Nov;5(11):1320-1335
HL-60 cells 5 μM 3 days BML-210 in combination with RA significantly accelerated and enhanced the maturation of HL-60 cells to granulocytes. Cell Mol Biol Lett. 2012 Dec;17(4):501-25.
NB4 cells 10 μM and 20 μM 24 h and 48 h BML-210 inhibited the proliferation and growth of NB4 cells in a dose- and time-dependent manner and promoted apoptosis. 10 μM BML-210 inhibited cell growth by 44% and 77% at 24 and 48 hours, respectively. 20 μM BML-210 inhibited cell growth by up to 90% at 48 hours. Additionally, BML-210 caused cell cycle arrest at the G0/G1 phase and induced apoptosis. Int J Mol Sci. 2015 Aug 6;16(8):18252-69

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice EO771 mammary tumor model Intraperitoneal injection 20 mg/kg Three times per week for two weeks Inhibit tumor growth and enhance the anti-tumor activity of CD8+ T cells Nat Biomed Eng. 2021 Nov;5(11):1320-1335

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.95mL

0.59mL

0.29mL

14.73mL

2.95mL

1.47mL

29.46mL

5.89mL

2.95mL

References

 

Historical Records

Categories